Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 06-2014 | 06-2013 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -476 | -301 | -1,027 | -19,727 | -29,442 |
| Depreciation Amortization | 1 | N/A | N/A | 6,494 | 20,987 |
| Income taxes - deferred | N/A | N/A | N/A | -1,539 | 3,651 |
| Accounts receivable | N/A | N/A | 308 | 3,202 | 6,686 |
| Accounts payable and accrued liabilities | 30 | -33 | -292 | -1,789 | -937 |
| Other Working Capital | 104 | 60 | 703 | 2,447 | -1,216 |
| Other Operating Activity | -37 | -516 | -16 | -338 | -2,744 |
| Operating Cash Flow | $-378 | $-790 | $-324 | $-11,250 | $-3,015 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 4,242 |
| PPE Investments | -1 | -1 | 15 | -41 | -682 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,740 |
| Other Investing Activity | 0 | 0 | 0 | 720 | 546 |
| Investing Cash Flow | $-1 | $-1 | $15 | $679 | $2,366 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 340 | 175 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -9 | -939 |
| Other Financing Activity | 0 | 0 | 31 | 0 | -1,900 |
| Financing Cash Flow | $340 | $175 | $31 | $-9 | $-2,839 |
| Exchange Rate Effect | N/A | N/A | N/A | -14 | -9 |
| Beginning Cash Position | 101 | 1,434 | 995 | 16,913 | 20,410 |
| End Cash Position | 62 | 818 | 717 | 6,319 | 16,913 |
| Net Cash Flow | $-39 | $-616 | $-278 | $-10,594 | $-3,497 |
| Free Cash Flow | |||||
| Operating Cash Flow | -378 | -790 | -324 | -11,250 | -3,015 |
| Capital Expenditure | -1 | -1 | N/A | -41 | -682 |
| Free Cash Flow | -379 | -791 | -324 | -11,291 | -3,697 |